A Catalyst for an Enantioselective Aza-Michael Addition
1
J1 = 16.6 Hz, J2 = 4.5 Hz, 1 H, 1-H), 3.28 (dd, J1 = 16.6 Hz, J2 =
ee. [α]2D0 = –2.4 (c = 1.0, CHCl3). H NMR (300 MHz, CDCl3): δ
7.9 Hz, 1 H, 1-H), 3.65 (m, 1 H, 1-H), 3.85 (m, 2 H, 1-H), 4.27 (m, = 3.27 (dd, J1 = 16.7 Hz, J2 = 5.4 Hz, 1 H, 1-H), 3.55 (dd, J1
=
2 H, 2-H), 4.69 (s, 2 H, 2-H), 7.19–7.41 (m, 5 H, Ar) ppm. 13C
NMR (90 MHz, CDCl3): δ = 18.3, 39.6, 42.4, 53.1, 61.9, 76.5,
127.8, 128.4, 128.5, 137.7, 153.6, 172.1 ppm. MS (IC): m/z (%) =
16.7 Hz, J2 = 8.4 Hz, 1 H, 1-H), 3.77–3.83 (m, 2 H, 2-H), 4.21–
4.27 (m, 2 H, 2-H), 4.55–4.68 (m, 1 H, 1-H), 4.60 (s, 2 H, 2-H),
7.24–7.42 (m, 10 H, Ar) ppm. 13C NMR (75 MHz, CDCl3): δ =
39.6, 42.4, 61.6, 62.0, 127.8, 128.0, 128.4, 128.6, 137.6, 140.1, 153.6,
279 [M + H]+. FTIR (KBr/CHCl ): ν = 1694 (max.), 1770, 1958,
˜
3
2253, 2923, 2971 cm–1. HRMS: calcd. for C14H19N2O4 279.1340; 171.5 ppm. FTIR (NaCl): ν = (max.) 1454, 1496, 1628, 1695, 1779,
+
˜
found 279.1345.
2924, 3031 cm–1. MS (CI): m/z (%) = 341 [M + H]+, 358 [M +
NH4]+. HRMS: calcd. for C19H20NO4Na+ 363.1321; found
363.1313.
3-[3-(Benzyloxyamino)hexanoyl]oxazolidin-2-one (3b): Oil (116 mg,
76% yield). The ee value of 3b was determined by HPLC analysis
using a Chiralcel OJ column, [hexane/EtOH, 90:10; flow is
1 mLmin–1; λ = 210 nm, tR = 36.0 min (major) and 40.9 min
(minor)]; 86% ee. [α]2D0 = –1.8 (c = 1.0, CHCl3). 1H NMR
(360 MHz, CDCl3): δ = 0.94 (t, J = 7.2 Hz, 3 H), 1.38–1.58 (m, 4
Supporting Information (see footnote on the first page of this arti-
cle): 1H and 13C NMR spectra of 3a, 3b, 3c, 3d, and 3e; HPLC
chromatograms of 3a, 3b, and 3c; 1D WINNMR deconvolution
for 3d.
H), 2.91 (dd, J1 = 16 Hz, J2 = 3.9 Hz, 1 H, 1-H), 3.23 (dd, J1
=
16 Hz, J2 = 8.5 Hz, 1 H, 1-H), 3.44–3.58 (m, 1 H, 1-H), 3.71–3.87
(m, 2 H, 2-H), 4.17–4.30 (m, 2 H, 2-H), 4.66 (s, 2 H, 2-H), 7.27–
7.37 (m, 5 H, Ar) ppm. 13C NMR (75 MHz, CDCl3): δ = 14.1,
19.4, 34.5, 38.2, 42.4, 57.5, 61.9, 76.3, 127.7, 128.3, 128.5, 137.8,
Acknowledgments
We thank the Centre National de la Recherche Scientifique
(CNRS) and the Ministère de l’Education Nationale de l’Enseigne-
ment Supérieur et de la Recherche for financial support.
153.7, 172.5 ppm. FTIR (NaCl): ν = 1455 (max.), 1689, 1779, 2873,
˜
2931, 2959 cm–1. MS (ESI): m/z (%) = 307 [M + H]+. HRMS:
+
calcd. for C16H23N2O4 307.1652; found 307.1661.
3-[3-(Benzyloxyamino)-4-methylpentanoyl]oxazolidin-2-one (3c): Oil
(90 mg, 59% yield). The ee value of 3c was determined by HPLC
analysis using a Chiralcel AD-H column, [hexane/EtOH, 90:10;
flow is 1 mLmin–1; λ = 204 nm, tR = 43.5 min (major) and 65.1 min
(minor)]; 52% ee. [α]2D0 = –1.0 (c = 1.0, CHCl3). 1H NMR
(300 MHz, CDCl3): δ = 0.96 (d, J = 6.8 Hz, 3 H, CH3), 0.99 (d, J
[1] a) P. W. Roesky, T. E. Müller, Angew. Chem. Int. Ed. 2003, 42,
2708–2710; b) S. Hong, T. J. Marks, Acc. Chem. Res. 2004, 37,
673–686; c) K. C. Hultzsch, Adv. Synth. Catal. 2005, 347, 367–
391; d) K. C. Hultzsch, Org. Biomol. Chem. 2005, 3, 1819–
1824; e) T. E. Müller, K. C. Hultzsch, M. Yus, F. Foubelo, M.
Tada, Chem. Rev. 2008, 108, 3795–3892; f) I. Aillaud, J. Collin,
J. Hannedouche, E. Schulz, Dalton Trans. 2007, 5105–5118; g)
S. C. Chemler, Org. Biomol. Chem. 2009, 7, 3009–3019.
[2] a) H. Sugihara, K. Daikai, X. L. Jin, H. Furuno, J. Inanaga,
Tetrahedron Lett. 2002, 43, 2735–2739; b) L. W. Xu, C. G. Xia,
Eur. J. Org. Chem. 2005, 633–639; c) J. L. Vicario, D. Badia, L.
Carillo, J. Etxebarria, E. Reyes, N. Ruiz, Org. Prep. Proced. Int.
2005, 37, 513–538; d) P. R. Krisna, A. Sreeshailam, R. Srinivas,
Tetrahedron 2009, 65, 9657–9672; e) D. Enders, C. Wang, J. X.
Liebich, Chem. Eur. J. 2009, 15, 11058–11076.
= 6.8 Hz, 3 H, CH3), 1.91–2.02 (m, 1 H, 1-H), 2.92 (dd, J1
=
15.5 Hz, J2 = 3.2 Hz, 1 H, 1-H), 3.22 (dd, J1 = 15.5 Hz, J2 = 9.5 Hz,
1 H, 1-H), 3.32–3.40 (m, 1 H, 1-H), 3.70–3.85 (m, 2 H, 2-H), 4.02–
4.27 (m, 2 H, 2-H), 4.66 (s, 2 H, 2-H), 7.27–7.43 (m, 5 H, Ar) ppm.
13C NMR (75 MHz, CDCl3): δ = 18.4, 19.2, 29.6, 35.1, 42.5, 61.8,
63.0, 76.0, 127.7, 128.2, 128.5, 137.8, 153.7, 172.9 ppm. FTIR
(NaCl): ν = 1453 (max.), 1680, 1779, 2928, 2965 cm–1. MS (ESI):
˜
m/z (%) = 307 [M + H]+. HRMS: calcd. for C16H23N2O4
+
[3] a) H. Sunden, R. Rios, I. Ibrahem, G. L. Zhao, L. Erikson, A.
Cordova, Adv. Synth. Catal. 2007, 349, 827–832; b) S. Fustero,
D. Jimenez, J. Moscardo, S. Catalan, C. del Pozo, Org. Lett.
2007, 9, 5283–5286; c) M. Guino, P. H. Phua, J. C. Caille, K. K.
Hii, J. Org. Chem. 2007, 72, 6290–6293.
[4] a) E. Juaristi, V. A. Soloshonk (Eds.), Enantioselective Synthe-
sis of β-Amino Acids, 2nd ed., Wiley-VCH, New York, 2005; b)
N. Sewald, Angew. Chem. Int. Ed. 2003, 42, 5794–5795; c) M.
Liu, M. P. Sibi, Tetrahedron 2002, 58, 7991–8035.
[5] a) K. Nakama, S. Seki, S. Kanemasa, Tetrahedron Lett. 2002,
43, 829–832; b) M. Gandelman, E. N. Jacobsen, Angew. Chem.
Int. Ed. 2005, 44, 2393–2397; c) C. Palomo, M. Oiarbide, R.
Halder, M. Kelso, E. Gomez-Bengoa, J. M. Garcia, J. Am.
Chem. Soc. 2004, 126, 9188–9189; d) M. S. Taylor, D. N. Zala-
tan, A. M. Lerchner, E. N. Jacobsen, J. Am. Chem. Soc. 2005,
127, 1313–1317; e) D. J. Guerin, S. J. Miller, J. Am. Chem. Soc.
2002, 124, 2134–2136.
307.1659; found 307.1658.
Ethyl 2-(Benzyloxyamino)-4-oxo-4-(2-oxooxazolidin-3-yl)butanoate
(3d): Oil (139 mg, 83% yield). The ee value of 3d was determined
by proton-decoupled 13C NMR spectroscopy in a PBLG/CD2Cl2
liquid crystal at 285 K (sample composition in mg is PBLG/3d/
CD2Cl2, 151.0:53.1:356.5). Deconvolution of the signals at δ =
154.13 ppm (major enantiomer) and 154.07 ppm (minor enantio-
mer), performed using a 1D WINNMR deconvolution routine, led
to a 83% ee. [α]2D0 = –8.0 (c = 1.0, CHCl3). 1H NMR (360 MHz,
CDCl3): δ = 1.28 (t, J = 7.2 Hz, 3 H, CH3), 3.31 (dd, J1 = 17.5 Hz,
J2 = 6.8 Hz, 1 H, 1-H), 3.42 (dd, J1 = 17.5 Hz, J2 = 5.7 Hz, 1 H,
1-H), 3.94 (t, J = 7.0 Hz, 2 H, 2-H), 4.12 (t, J = 6.0 Hz, 1 H, 1-H),
4.22 (q, J = 7.2 Hz, 2 H, CH2OEt), 4.35 (t, J = 7.0 Hz, 2 H, 2-H),
4.70 (s, 2 H, 2-H), 7.30–7.38 (m, 5 H, Ar) ppm. 13C NMR
(75 MHz, CDCl3): δ = 14.1, 35.2, 42.3, 59.6, 61.4, 62.1, 76.4, 127.8,
[6] a) W. Zhuang, R. G. Hazell, K. A. Jorgensen, Chem. Commun.
2001, 1240–1241; b) Y. Hamashima, H. Somei, Y. Shimura, T.
Tamura, M. Sodeoka, Org. Lett. 2004, 6, 1861–1864; c) K. K.
Hii, Pure Appl. Chem. 2006, 78, 341–349; d) P. H. Phua, A. J. P.
White, J. G. de Vries, K. K. Hii, Adv. Synth. Catal. 2006, 348,
587–592; e) P. H. Phua, S. P. Mathew, A. J. P. White, J. G.
de Vries, D. G. Blackmond, K. K. Hii, Chem. Eur. J. 2007, 13,
4602–4613; f) S. H. Kang, Y. K. Kang, D. Y. Kim, Tetrahedron
2009, 65, 5676–5679.
[7] a) X. L. Jin, H. Sugihara, K. Daikai, H. Tateishi, Y. Z. Jin, H.
Furuno, J. Inanaga, Tetrahedron 2002, 58, 8321–8329; b) H.
Sugihara, K. Daikai, X. L. Jin, H. Furuno, J. Inanaga, Tetrahe-
dron Lett. 2002, 43, 2735–2739.
128.3, 128.6, 137.6, 153.4, 170.4, 171.6 ppm. FTIR (NaCl): ν =
˜
1456 (max.), 1668, 1728, 1782, 2982 cm–1. MS (ESI): m/z (%) =
337 [M + H]+. HRMS: calcd. for C16H21N2O6 337.1394; found
+
337.1399.
3-(Benzyloxyamino)-3-(3-phenylpropanoyl)oxazolidin-2-one (3e): Oil
(97 mg, 57% yield). The ee of 3e was determined by proton-decou-
pled 13C NMR spectroscopy in a PBLG/CD2Cl2 liquid crystal at
285 K (sample composition in mg is PBLG/3e/CD2Cl2,
151.0:53.1:356.5). Deconvolution of the signals at δ = 128.04 ppm
(major enantiomer) and 128.00 ppm (minor enantiomer), per-
formed using a 1D WINNMR deconvolution routine, led to a 7%
Eur. J. Org. Chem. 2011, 2678–2684
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
2683